药物优化诊所降低了心力衰竭患者的住院和死亡率,减少了喷射分数
James C Coons1,2, Jennifer Kliner2, Michael A Mathier2
1Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, United States of America.
American heart journal plus : cardiology research and practice
|November 6, 2024
概括
一个药物优化诊所 (MOC) 显著改善了心力衰竭与减少喷射率 (HFrEF) 的指南导向医学治疗 (GDMT). 这导致HFrEF患者的住院和死亡率降低.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 以指导方针为导向的医疗疗 (GDMT) 对于管理心力衰竭与减少喷射率 (HFrEF) 至关重要.
- 在常规的临床实践中,优化GDMT可能具有挑战性.
- 药物优化诊所 (MOC) 提供了一种结构化的方法来改善药物管理.
研究的目的:
- 评估药物优化诊所 (MOC) 对HFrEF患者的GDMT遵守和临床结果的影响.
- 为了比较由MOC管理的患者与接受常规护理的患者的结果.
主要方法:
- 在一个大型医疗系统中,对一个多站点MOC计划的回顾性评估.
- 将MOC组的1419名患者与接受常规护理的5116名对照患者进行比较.
- 分析使用GDMT,心力衰竭 (HF) 住院,心血管 (CV) 住院以及使用竞争性风险分析的所有原因死亡率.
主要成果:
- 与对照组相比,MOC患者的四重疗法,ARNI,β-阻断剂,MRA和SGLT2抑制剂使用率显着更高.
- 竞争的风险分析显示,MOC组在3,6个月和12个月内,HF和CV住院病例显著降低.
- 在MOC组中,所有原因的死亡率在6个月和12个月显著降低,但在3个月后却没有降低.
结论:
- MOCs有效地改善了HFrEF患者的GDMT坚持.
- MOC干预与降低HF和心血管住院病例有关.
- MOCs有助于降低HFrEF患者全因死亡率.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
01:22Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
01:22Heart Failure Drugs: β-Blockers
319
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
319
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:28Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
01:14Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2